In this Ocular Surgery News publication exclusive, Kristen Dunbar, MD, and Caroline Baumal, MD, of the New England Eye Center at Tufts University School of Medicine, discuss a case in which a fundus exam of the left eye showed an inferotemporal excavation in the optic nerve head with a serous retinal detachment.A 19-year-old female college student was referred by an outside optometrist for retinal evaluation of her left eye. She initially presented for a routine annual exam with no visual complaints. On further questioning, she noted occasional “sparks” in her (Read more...)
Merck announces Q2 financial results
Merck’s second-quarter worldwide sales were $10.9 billion, marking a 1% decrease from the same time last year, according to a company press release. Pharmaceutical sales declined by 2% to $9.1 billion, while second-quarter global sales of consumer care products were $583 million, marking a 19% increase from the previous period in 2013.
Poll shows 25 million older adults received unwanted medical care
About 25 million older Americans have been subjected to unwanted or excessive medical treatments, according to new survey data. The research was sponsored by Compassion & Choices, a nonprofit, end-of-life patient advocacy group. A poll of 1,007 individuals aged 50 years and older was conducted by Purple Insights, a research division of Purple Strategies.
Digital reading system for the blind, allows them to read graphs
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
Automatic Test Detects Secondary Cataracts with High Precision
After cataract surgery a troubling number of patients develop posterior capsule opacity, also known as a “secondary cataract,” whereby a cloudy membrane develops behind the newly implanted lens. Recognizing this condition normally requires expert analysis, and while automated systems exist that detect lens opacity, they are not looking (Read more...)
FDA OKs Aflibercept (Eylea) for Diabetic Macular Edema
The drug is the first VEGF inhibitor that can be taken for less than once a month for this eye problem, the manufacturer has noted. FDA Approvals